Patents Assigned to Fina BioSolutions, LLC
  • Publication number: 20230242961
    Abstract: The invention is directed to methods and compositions for the expression and purification of products such as peptides and proteins in microorganisms. In particular, pre-products are expressed recombinantly, wherein the cytoplasm of the microorganism alters the expressed pre-products to produce products in an active/final or otherwise desirable form. Alterations associated with expression of a desired recombinant product include shifting of the redox state of the cytoplasm to allow proper protein folding, site-directed cleavage of pre-proteins to activate the protein, site-directed cleavage of an unwanted methionine from the N terminus of the protein, and/or one or more ligations to form desired protein configurations, all within the same cell.
    Type: Application
    Filed: March 12, 2021
    Publication date: August 3, 2023
    Applicant: Fina BioSolutions, LLC
    Inventors: Min-Ju Chang, Natalia Oganesyan, Andrew Lees
  • Publication number: 20230122876
    Abstract: This invention provides novel reagents for cyanating polysaccharides in aqueous or part aqueous solutions so that they may be covalently linked to peptides or proteins either directly or through a spacer. These reagents include 1-cyano-4-dimethylaminopyridinium bromide, or a functional derivative or modification thereof. The examples illustrate the use of these reagents with a variety of polysaccharides and proteins showing that the methods are generally applicable.
    Type: Application
    Filed: October 11, 2022
    Publication date: April 20, 2023
    Applicant: Fina BioSolutions, LLC
    Inventor: Andrew Lees
  • Publication number: 20210348174
    Abstract: The present invention is directed to the cells, compositions and methods for the production of recombinant protein, wherein an f-met group on the 5?-terminus is enzymatically removed. In particular, the invention is directed to a production process for obtaining high levels of soluble recombinant CRM197 protein from E. coli. Cells preferably contain one or more mutations of disulfide reductase genes, so that disulfide reductase activity is reduced. The invention also relates to purification method for CRM197 as well as characterization of properly folded CRM197 protein.
    Type: Application
    Filed: July 9, 2021
    Publication date: November 11, 2021
    Applicant: Fina BioSolutions, LLC
    Inventors: Min-Ju Chang, Natalia Oganesyan, Andrew Lees
  • Patent number: 11060123
    Abstract: The present invention is directed to the cells, compositions and methods for the production of recombinant protein, wherein an f-met group on the 5?-terminus is enzymatically removed. In particular, the invention is directed to a production process for obtaining high levels of soluble recombinant CRM197 protein from E. coli. Cells preferably contain one or more mutations of disulfide reductase genes, so that disulfide reductase activity is reduced. The invention also relates to purification method for CRM197 as well as characterization of properly folded CRM197 protein.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: July 13, 2021
    Assignee: Fina BioSolutions, LLC
    Inventors: Natalia Oganesyan, Andrew Lees, Min-Ju Chang
  • Publication number: 20200216872
    Abstract: The present invention is directed to the cells, compositions and methods for the production of recombinant protein, wherein an f-met group on the 5?-terminus is enzymatically removed. In particular, the invention is directed to a production process for obtaining high levels of soluble recombinant CRM197 protein from E. coli. Cells preferably contain one or more mutations of disulfide reductase genes, so that disulfide reductase activity is reduced. The invention also relates to purification method for CRM197 as well as characterization of properly folded CRM197 protein.
    Type: Application
    Filed: March 16, 2020
    Publication date: July 9, 2020
    Applicant: Fina BioSolutions, LLC
    Inventors: Natalia Oganesyan, Andrew Lees
  • Patent number: 10597664
    Abstract: The present invention is directed to the cells, compositions and methods for the production of recombinant protein. In particular, the invention is directed to a production process for obtaining high levels of soluble recombinant CRM197 protein from E. coli. Cells preferably contain one or more mutations of disulfide reductase genes, so that disulfide reductase activity is reduced. The invention also relates to purification method for CRM197 as well as characterization of properly folded CRM197 protein.
    Type: Grant
    Filed: October 8, 2018
    Date of Patent: March 24, 2020
    Assignee: Fina BioSolutions, LLC
    Inventors: Natalia Oganesyan, Andrew Lees
  • Publication number: 20190032063
    Abstract: The present invention is directed to the cells, compositions and methods for the production of recombinant protein. In particular, the invention is directed to a production process for obtaining high levels of soluble recombinant CRM197 protein from E. coli. Cells preferably contain one or more mutations of disulfide reductase genes, so that disulfide reductase activity is reduced. The invention also relates to purification method for CRM197 as well as characterization of properly folded CRM197 protein.
    Type: Application
    Filed: October 8, 2018
    Publication date: January 31, 2019
    Applicant: Fina BioSolutions, LLC
    Inventors: Natalia Oganesyan, Andrew Lees
  • Patent number: 10093704
    Abstract: The present invention is directed to the cells, compositions and methods for the production of recombinant protein. In particular, the invention is directed to a production process for obtaining high levels of soluble recombinant CRM197 protein from E. coli. Cells preferably contain one or more mutations of disulfide reductase genes, so that disulfide reductase activity is reduced. The invention also relates to purification method for CRM197 as well as characterization of properly folded CRM197 protein.
    Type: Grant
    Filed: February 2, 2015
    Date of Patent: October 9, 2018
    Assignee: Fina BioSolutions, LLC
    Inventors: Natalia Oganesyan, Andrew Lees
  • Publication number: 20160333057
    Abstract: The present invention is directed to the cells, compositions and methods for the production of recombinant protein. In particular, the invention is directed to a production process for obtaining high levels of soluble recombinant CRM197 protein from E. coli. Cells preferably contain one or more mutations of disulfide reductase genes, so that disulfide reductase activity is reduced. The invention also relates to purification method for CRM197 as well as characterization of properly folded CRM197 protein.
    Type: Application
    Filed: February 2, 2015
    Publication date: November 17, 2016
    Applicant: FINA BIOSOLUTIONS, LLC
    Inventors: Natalia OGANESYAN, Andrew LEES
  • Patent number: 9259480
    Abstract: This invention provides novel reagents for cyanating polysaccharides in aqueous or part aqueous solutions so that they may be covalently linked to proteins either directly or through a spacer. These reagents include 1-cyano-4-pyrrolidinopyridinium tetrafluoroborate (CPPT), 1-cyano-imidazole (1-CI), 1-cyanobenzotriazole (1-CBT), or 2-cyanopyridazine-3(2H)one (2-CPO), or a functional derivative or modification thereof. The examples illustrate the use of these reagents with a variety of polysaccharides and proteins showing that the methods are generally applicable.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: February 16, 2016
    Assignee: Fina BioSolutions LLC
    Inventor: Andrew Lees
  • Patent number: 9254337
    Abstract: This invention provides novel reagents for cyanating polysaccharides in aqueous or part aqueous solutions so that they may be covalently linked to proteins either directly or through a spacer. These reagents include 1-cyano-4-pyrrolidinopyridinium tetrafluoroborate (CPPT), 1-cyano-imidazole (1-CI), 1-cyanobenzotriazole (1-CBT), or 2-cyanopyridazine-3(2H)one (2-CPO), or a functional derivative or modification thereof. The examples illustrate the use of these reagents with a variety of polysaccharides and proteins showing that the methods are generally applicable.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: February 9, 2016
    Assignee: Fina BioSolutions, LLC
    Inventor: Andrew Lees
  • Patent number: 9248197
    Abstract: This invention provides novel reagents for cyanating polysaccharides in aqueous or part aqueous solutions so that they may be covalently linked to proteins either directly or through a spacer. These reagents include 1-cyano-4-pyrrolidinopyridinium tetrafluoroborate (CPPT), 1-cyano-imidazole (1-CI), 1-cyanobenzotriazole (1-CBT), or 2-cyanopyridazine-3(2H)one (2-CPO), or a functional derivative or modification thereof. The examples illustrate the use of these reagents with a variety of polysaccharides and proteins showing that the methods are generally applicable.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: February 2, 2016
    Assignee: Fina BioSolutions, LLC
    Inventor: Andrew Lees
  • Patent number: 9044517
    Abstract: This invention provides novel reagents for cyanating polysaccharides in aqueous or part aqueous solutions so that they may be covalently linked to proteins either directly or through a spacer. These reagents include 1-cyano-4-pyrrolidinopyridinium tetrafluoroborate (CPPT), 1-cyano-imidazole (1-CI), 1-cyanobenzotriazole (1-CBT), or 2-cyanopyridazine-3(2H)one (2-CPO), or a functional derivative or modification thereof. The examples illustrate the use of these reagents with a variety of polysaccharides and proteins showing that the methods are generally applicable.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: June 2, 2015
    Assignee: Fina BioSolutions, LLC
    Inventor: Andrew Lees
  • Publication number: 20140186388
    Abstract: This invention is directed to processes for reducing the level of free carbohydrate from a solution of protein-linked carbohydrate (conjugate) and non-linked carbohydrate. In this process, the conjugate is adsorbed to a hydrophobic membrane while the carbohydrate is not. The conjugate is then desorbed from the membrane, yielding a solution that is substantially reduced in free carbohydrate.
    Type: Application
    Filed: January 29, 2014
    Publication date: July 3, 2014
    Applicant: Fina BioSolutions, LLC
    Inventor: Andrew Lees
  • Patent number: 8647621
    Abstract: This invention is directed to processes for reducing the level of free carbohydrate from a solution of protein-linked carbohydrate (conjugate) and non-linked carbohydrate. In this process, the conjugate is adsorbed to a hydrophobic membrane while the carbohydrate is not. The conjugate is then desorbed from the membrane, yielding a solution that is substantially reduced in free carbohydrate.
    Type: Grant
    Filed: July 27, 2010
    Date of Patent: February 11, 2014
    Assignee: Fina BioSolutions, LLC
    Inventor: Andrew Lees
  • Patent number: 8383783
    Abstract: This invention is directed to methods for removing, preferably simultaneously and in one step, multiple impurities form crude culture samples, and, in particular, the removal of media components, protein, nucleic acids, lipids, and lipopolysaccharides to ultralow levels. Preferably the purification process comprises: (1) binding of the target substance containing one or more contaminants to a chromatography matrix; (2) washing the bound target substance with one or more buffers containing a synergistic combination of a lyotropic agent or organic solvent, a detergent, and a salt component; and (3) desorbing the target substance from the chromatography matrix, so that the eluate contains ultra low levels of contaminants. The reduction of impurities that can be achieved is preferably 91-99.9% as compared to the amount of impurities in the target substance before purification. The invention is also directed to the targets products that have been so purified.
    Type: Grant
    Filed: December 20, 2010
    Date of Patent: February 26, 2013
    Assignees: Serum Institute of India, Ltd., Fina BioSolutions, LLC
    Inventors: Andrew Lees, Jayant Sakaram Joshi
  • Publication number: 20120135030
    Abstract: This invention is directed to processes for reducing the level of free carbohydrate from a solution of protein-linked carbohydrate (conjugate) and non-linked carbohydrate. In this process, the conjugate is adsorbed to a hydrophobic membrane while the carbohydrate is not. The conjugate is then desorbed from the membrane, yielding a solution that is substantially reduced in free carbohydrate.
    Type: Application
    Filed: July 27, 2010
    Publication date: May 31, 2012
    Applicant: Fina BioSolutions, LLC
    Inventor: Andrew Lees